Page 826 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat

782 INDEX INDEX

Methylenetetrahydrofolate reductase Micromelia, 614 Mitral valve prolapse, 291 MPO-ANCA/p-ANCA autoantibody,
(MTHFR) deficiency, 84 Microphthalmia, 63 fragile X syndrome, 62 115
Methylmalonic acid MicroRNA (miRNA), 42, 56 Marfan syndrome, 52 M protein
vitamin B deficiency, 69 Microscopic polyangiitis, 315 renal cyst disorders and, 604 rheumatic fever and, 136
12
vitamin B deficiency, 68 Microsporum, 152 Mittelschmerz, 631 as virulence factor, 129
9
Methylmalonyl-CoA mutase, 69 Microtubule inhibitors, 441 Mixed cellularity lymphoma, 429 mRNA
Methylmercury teratogenicity, 614 Microtubules, 48 Mixed connective tissue disease, 470 aminoglycosides, 191
Methylnaltrexone, 551 drugs acting on, 48 autoantibody, 115 hepatitis viruses, 172
Methylphenidate structure and function of, 48 Raynaud phenomenon, 472 pre-mRNA splicing, 42
ADHD, 557, 572 Micturition center, 237 Mixed cryoglobulinemia, 315 processing, 41
CNS stimulant, 572 Midazolam, 546, 550 Mixed transcortical aphasia, 516 protease inhibitors, 203
Methyltestosterone, 658 Midbrain MMR vaccine, 170 stop codons, 44
Methylxanthines, 687 brain, 490 Mobitz AV blocks, 295 MRSA (methicillin-resistant
Metoclopramide, 400 cranial nerve nuclei of, 505 Moccasin distribution (tinea pedis), 152 Staphylococcus aureus)
Parkinson-like syndrome, 251 lesions in, 511 Modafinil, 568 cephalosporins, 189
tardive dyskinesia, 251 Middlebrook medium, 126 Mode (statistics), 262 highly resistant, 198
Metolazone, 609 Middle cerebral artery (MCA) Molecular mimicry nosocomial infections, 135
Metoprolol, 245, 323 cortical distribution, 502 autoimmune response in oxazolidinones, 193
Metronidazole saccular aneurysms, 516 rheumatic fever, 129 vancomycin, 190
bacterial vaginosis, 148 stroke effects, 514 Molecular motor proteins, 48 mTOR
clindamycin vs, 192 Middle meningeal artery Molluscum contagiosum, 164, 479 sirolimus (rapamycin) inhibition
Clostridium difficile, 138 epidural hematoma and, 513 Mönckeberg sclerosis, 301 of, 120
for Crohn disease, 382 Middle rectal vein, 365 “Monday disease,” 318 Mucicarmine stain
disulfiram-like reaction, 251 Midgut Monoamine oxidase (MAO) inhibitors polysaccharide capsule staining, 125
Giardia lamblia, 155 blood supply/innervation of, 364 atypical depression, 561 Mucinous cystadenocarcinoma, 646
Helicobacter pylori, 146 development of, 358 mechanism and clinical use, 575 Mucinous cystadenoma, 646
mechanism and use, 195 Midgut volvulus, 386 Parkinson disease, 549 Mucociliary escalator, 662
vaginal infections, 181 Midodrine, 242 selegiline/rasagiline, 549 Mucocutaneous lymph node
vaginitis, 158 Mifepristone, 657 tyramine and, 244 syndrome, 314
Mevalonate synthesis, 320 Miglitol, 353 Monobactams, 190 Mucoepidermoid carcinomas, 376
Mexiletine, 322 Migraine headaches, 518 Pseudomonas aeruginosa, 143 Mucopolysaccharides
Meyer loop, 542 hormonal contraception Monoclonal antibodies Periodic acid-Schiff stain, 125
MHC (major histocompatibility contraindication, 657 drug names for, 254 Mucopolysaccharidoses, 88
complex) I and II, 100 triptans for, 547 Monoclonal immunoglobulin (Ig) Mucormycosis
Micafungin, 200 Migrating motor complexes (MMC), overproduction, 431 diabetic ketoacidosis, 347
Michaelis-Menten kinetics, 230 371 Monocytes, 407 Mucor spp
Miconazole, 199 Migratory polyarthritis, 312 innate immunity, 99 amphotericin B for, 199
Microalbuminuria, 346 Milnacipran, 575 morulae in, 150 opportunistic infection, 153
Microangiopathic hemolytic anemia Mineralocorticoids Monospot test, 165 Mucosa, 362
(MAHA), 423 adrenal insufficiency, 349 Monozygotic (“identical”) twins, 616 Mucosal cells, 372
hypertensive emergency and, adrenal steroids and, 335 Montelukast, 687 Mucosal neuromas, 351
300 Mineral oil, 65 Mood Mucosal polyps, 387
intravascular hemolysis in, 421 Minimal alveolar concentration, oxytocin’s role in regulating, 328 Mucositis
Microarrays, 54 549 Mood disorder, 560 methotrexate, 440
Microbiology, 123–204 Minocycline, 192 readmissions with, 272 Mucus, 238
antimicrobials, 187–204 Minors, consent for, 265 Mood stabilizing drugs, 561 “Muddy brown” casts (urine), 594
bacteriology, 124–134 Minoxidil, 658 Morbidly adherent placenta, 640 Mulberry molars, 147
clinical bacteriology, 134–150 Minute ventilation, 664 Moro reflex, 510, 635 Müllerian duct
mycology, 151–154 Miosis Morphine, 551 agenesis, 622
oncogenic organisms, 226 cholinomimetic agents, 552 for acute coronary syndromes, 307 anomalies of, 623
parasitology, 155–161 Horner syndrome, 531, 540 intoxication and withdrawal, 570 derivatives of, 622
systems, 178–186 pupillary control, 539 Morphogenesis Müllerian inhibitory factor (MIF), 622
virology, 162–177 sympatholytic drugs, 243 of heart, 280–281 Sertoli cell production, 628
Microbiome Mirabegron, 242 errors in, 613 Multicystic dysplastic kidney, 578, 579
in innate immunity, 99 Mirtazapine, 244, 576 Morulae, 150 Multidrug resistance protein 1
Microcephaly, 63 major depressive disorder, 561 Mosaic bone architecture, 464 (MDR1), 227
cri-du-chat syndrome, 64 Mismatch repair, 40 Mosaicism, 57 Multifactorial pulmonary
fetal alcohol syndrome, 615 Misoprostol, 399 Mosquitoes (disease vectors) hypertension, 679
maternal phenylketonuria, 84 Missense mutations, 39 lymphatic filariasis, 159 Multiorgan drug reactions, 251
maternal X-ray exposure, 614 Mites/louse treatment, 200 malaria, 157 Multiple endocrine neoplasias (MEN
Patau syndrome, 63 Mitochondria Zika virus, 171 syndromes), 351
with zika virus, 171 high altitude and, 670 Motilin, 371 Zollinger-Ellison syndrome, 351
Microcytic, hypochromic anemia, metabolism in, 72 Motion sickness, 241 Multiple gestations, 633
418–419 Mitochondrial encephalopathy, 59 Motor cortex, 514 Multiple myeloma
Ancylostoma, 161 Mitochondrial inheritance, 59 descending spinal tracts, 509 bortezomib/carfilzomib in, 443
Microcytosis, 214 Mitochondrial myopathies, 59 topographic representation, 502 common metastases, 223
Microdeletion Mitosis, 46 ventral lateral thalamus and, 498 ESR in, 214
congenital, 64 griseofulvin, 200 Motor innervation metastatic calcification, 211
fluorescent in situ hybridization Mitral regurgitation, 288 derivation of, 620 monoclonal gammopathy
and, 55 in MI, 305 lower extremity, 452 transition to, 431
22q11, 116 murmurs caused by, 290, 291 tongue, 493 plasma cell dyscrasia, 409
Microfilaments, 48 Mitral stenosis, 288 Motor neuron signs, 529 Multiple personality disorder, 558
Microglia, 490, 493 murmurs caused by, 291 Movement disorders, 519 Multiple sclerosis, 523
Micrognathia Mitral valve dopaminergic pathways and, 499 drug therapy for, 551
Edwards syndrome, 63 in cardiac cycle, 287 Moxifloxacin, 195 HLA-DR2 and, 100
Pierre Robin sequence, 620 regurgitation in, 312 M phase, 46 internuclear ophthalmoplegia, 543

FAS1_2019_21_Index_749-806.indd 782 11/21/19 12:27 PM